{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "CNBC"}, "author": "Annika Kim Constantino, Ashley Capoot", "title": "Healthy Returns: 1 in 8 adults have taken Ozempic or other GLP-1s, survey says - CNBC", "description": "Many Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind's new AI model can predict the structure of molecules.", "url": "https://www.cnbc.com/2024/05/14/healthy-returns-1-in-8-adults-have-taken-glp-1s-like-ozempic-survey.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/107409559-17146662762023-12-01t121433z_781430601_rc29d4aur2jz_rtrmadp_0_health-obesity-novonordisk-doctors.jpeg?v=1714666322&w=1920&h=1080", "publishedAt": "2024-05-14T18:35:49Z", "content": "Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.\r\nGood afternoon! The use of a buzzy class of weight loss and diabetes medications is more common t\u2026 [+5487 chars]"}]}